Fibroscan

FibroScan: The Gold Standard for Non-Invasive Liver Assessment

FibroScan (Transient Elastography) is an advanced, non-invasive diagnostic tool used to assess liver stiffness and fat content, playing a crucial role in evaluating chronic liver diseases such as MAFLD, viral hepatitis, alcohol-related liver disease, and cirrhosis. By measuring Liver Stiffness Measurement (LSM) in kilopascals (kPa) and Controlled Attenuation Parameter (CAP) in dB/m, FibroScan helps quantify fibrosis (scarring) and steatosis (fat accumulation) with high accuracy, reducing the need for liver biopsies.

Key Features & Clinical Utility:

🔹 Quick & Painless: Takes 5-10 minutes, performed at the bedside, and requires no sedation.

🔹 Early Detection: Identifies fibrosis progression in at-risk populations before symptoms appear.

🔹 Risk Stratification: Differentiates between simple fatty liver and advanced fibrosis/cirrhosis, guiding treatment decisions.

🔹 Monitoring Tool: Tracks liver disease progression or regression post-intervention (weight loss, antiviral therapy, or metabolic control).

Interpreting Results:

✔️ CAP Score (dB/m):

<248 dB/m: Minimal or no fat

248–280 dB/m: Mild steatosis

>280 dB/m: Significant fat accumulation (severe steatosis)

✔️ LSM (kPa):

<7 kPa: No/mild fibrosis

7-12 kPa: Moderate fibrosis (F2-F3)

>12 kPa: Advanced fibrosis/cirrhosis (F4)

Why It Matters?

With the rising burden of MAFLD & liver-related complications, FibroScan is transforming hepatology practice—allowing early diagnosis, risk prediction, and personalized liver care without invasive procedures.

#FibroScan #LiverHealth #FattyLiver #Cirrhosis #Hepatology #NonInvasiveTesting #PrecisionMedicine

#drchetankalal #besthepatologistmumbai # besthepatologistindia